Maprotiline-induced ataxia.
D000873:Anthracenes / Q000009:adverse effects*; D002524:Cerebellar Ataxia / Q000139:chemically induced*; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged
D000873:Anthracenes; D008376:Maprotiline